The global single-use bioreactors market is projected to reach a staggering $6.7 billion by 2034, fueled by the increasing demand for biologics, biosimilars, and gene and cell therapies. This market is driven by cost-effectiveness, flexibility, and advancements in technology. North America holds the largest market share, with ongoing growth expected across the globe.